0001558370-23-019691.txt : 20231208 0001558370-23-019691.hdr.sgml : 20231208 20231208160535 ACCESSION NUMBER: 0001558370-23-019691 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231207 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231208 DATE AS OF CHANGE: 20231208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-PATH HOLDINGS INC CENTRAL INDEX KEY: 0001133818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870652870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36333 FILM NUMBER: 231475402 BUSINESS ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 BUSINESS PHONE: (832) 742-1357 MAIL ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 FORMER COMPANY: FORMER CONFORMED NAME: OGDEN GOLF CO CORP DATE OF NAME CHANGE: 20010205 8-K 1 bpth-20231207x8k.htm 8-K
0001133818false--12-3100011338182023-12-072023-12-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): December 7, 2023

BIO-PATH HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

001-36333

    

87-0652870

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

4710 Bellaire Boulevard, Suite 210, Bellaire, Texas

    

77401

(Address of principal executive offices)

(Zip Code)

(832) 742-1357

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol

    

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

BPTH

 

The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On December 7, 2023, the Board of Directors (the “Board”) of Bio-Path Holdings, Inc. (the “Company”) approved Amendment No. 1 to the First Amended and Restated Bylaws of the Company for the purpose of reducing the threshold required to establish a quorum for its meetings of stockholders from a majority of shares entitled to vote at such meetings to one-third of the shares entitled to vote at such meetings. The amendment became effective upon adoption by the Board.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

 

 

Number

 

Description

 

 

 

3.1

 

Amendment No. 1 to First Amended and Restated Bylaws of Bio-Path Holdings, Inc.

104

The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

BIO-PATH HOLDINGS, INC.  

 

 

 

Dated: December 8, 2023

By:

/s/ Peter H. Nielsen

 

 

Peter H. Nielsen

 

 

President and Chief Executive Officer

EX-3.1 2 bpth-20231207xex3d1.htm EX-3.1

Exhibit 3.1

BIO-PATH HOLDINGS, INC.
(a Delaware corporation)

(the “Company”)

AMENDMENT NO. 1
TO
FIRST AMENDED AND RESTATED BYLAWS

Pursuant to Section 8.4 of the First Amended and Restated Bylaws (the “Bylaws”) of the Company, the Bylaws were amended by unanimous approval of the members of the Board of Directors of the Company as follows:

1.Section 2.5 of the Bylaws is hereby deleted in its entirety and replaced with the following:

“Section 2.5Quorum. Except as otherwise provided by applicable law, the Certificate of Incorporation or these Bylaws, the presence in person or by proxy of the holders of stock having one-third of the votes which could be cast by the holders of all outstanding stock entitled to vote at the meeting shall constitute a quorum at each meeting of stockholders. In the absence of a quorum, the stockholders so present may, by the affirmative vote of the holders of stock having a majority of the votes which could be cast by all such holders, adjourn the meeting from time to time in the manner provided in Section 2.4 of these Bylaws until a quorum is present. If a quorum is present when a meeting is convened, the subsequent withdrawal of stockholders, even though less than a quorum remains, shall not affect the ability of the remaining stockholders lawfully to transact business.”

2.Except as set forth above, the Bylaws shall remain in full force and effect.

[Remainder of Page Intentionally Left Blank]


I hereby certify that the amendments to the Bylaws of the Company set forth herein were duly adopted by the Board of Directors of the Company on December 7, 2023.

/s/ Douglas P. Morris​ ​

Douglas P. Morris, Secretary


EX-101.SCH 3 bpth-20231207.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 bpth-20231207_lab.xml EX-101.LAB EX-101.PRE 5 bpth-20231207_pre.xml EX-101.PRE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document and Entity Information
Dec. 07, 2023
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Dec. 07, 2023
Entity File Number 001-36333
Entity Registrant Name BIO-PATH HOLDINGS, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 87-0652870
Entity Address State Or Province TX
Entity Address, Address Line One 4710 Bellaire Boulevard
Entity Address, Adress Line Two Suite 210
Entity Address, City or Town Bellaire
Entity Address, Postal Zip Code 77401
City Area Code 832
Local Phone Number 742-1357
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol BPTH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001133818
Current Fiscal Year End Date --12-31
Amendment Flag false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 7 bpth-20231207x8k_htm.xml IDEA: XBRL DOCUMENT 0001133818 2023-12-07 2023-12-07 0001133818 false --12-31 8-K 2023-12-07 BIO-PATH HOLDINGS, INC. DE 001-36333 87-0652870 4710 Bellaire Boulevard Suite 210 Bellaire TX 77401 832 742-1357 false false false false Common Stock, par value $0.001 per share BPTH NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;'-02P$"% ,4 " "O@(A799!YDAD! #/ P $P M @ 'G$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" Q %% ! end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 24 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports bpth-20231207.xsd bpth-20231207_lab.xml bpth-20231207_pre.xml bpth-20231207x8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bpth-20231207x8k.htm": { "nsprefix": "bpth", "nsuri": "http://www.biopathholdings.com/20231207", "dts": { "schema": { "local": [ "bpth-20231207.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "bpth-20231207_lab.xml" ] }, "presentationLink": { "local": [ "bpth-20231207_pre.xml" ] }, "inline": { "local": [ "bpth-20231207x8k.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_12_7_2023_To_12_7_2023__RerYockyEu-x3JRA71UdA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "bpth-20231207x8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_12_7_2023_To_12_7_2023__RerYockyEu-x3JRA71UdA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "bpth-20231207x8k.htm", "first": true, "unique": true } } }, "tag": { "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Adress Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001558370-23-019691-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-23-019691-xbrl.zip M4$L#!!0 ( *^ B%>$"-0K> , &8, 1 8G!T:"TR,#(S,3(P-RYX M]QI:VJ@740I2I190*5+?D.-U$@NOO=C>)OU[QLYZ M$V]VTX#@J5O/F3-GQC/CG%VN2HZ>J-),BO-1%JOSMY$T>/5_2TJ)*E+*@PBBF)#"[1D9H$>9%5A@>ZH4HQS=*58,:<(96G\ M-D[C;(RBJ"&YPAJ0H15_O6N = M")RQ%Y$K74PT6= 2(X/5G)K/N*2ZPH2>CQ;&5),D62Z7\93)"IO%0G*;MHZ) M+!U?EJ?O1@@;H]BT-O235.4UG>&:&RB-^%5C[D1 Q3BU!0D 6V8HL= 3$!-$ M78YCJ>80*,V2Q[O;;TZG!T/EYQA7K<,,ZZF#-P:GSX,5G07,JZGBGOLX :L' M:F4B\UQ1O1]U-X2,O-!R>/D\9:)GQXI,",Z ME* IB>?R*7&F@-:F,2"C-04.M5�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end